The case of avian influenza A (H5) confirmed by the Centers for Disease Control and Prevention in Missouri, USA, on Sept 6, 2024,1 has reignited concerns about the risk of human contagion and the need ...

COVID has changed so much from the first few years of the pandemic, when people got those first vaccines in 2021,” said Dr. Doug Pogue, president of BJC Medical Group.

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the ...

Moderna is facing allegations that it misused innovations from researchers at Northwestern University to develop its mRNA COVID-19 vaccines, which became widely available to the public in 2021 to ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial.

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

Discover the groundbreaking mRNA vaccine developed by University of Pennsylvania and Children's Hospital of Philadelphia to prevent and treat C. difficile ...

Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...

The FDA approved the company's COVID vaccine in October 2023. The stock has gained 111% in the year to date, while the S&P 500 SPX has gained 22%. This content was created by MarketWatch, which is ...